Status

This opportunity is still open. If you are interested in applying for this award, please contact Karen Drew (x4824) as soon as possible.

Deadlines
  • Internal: 01/07/2020
  • LOI: 02/28/2020

Funding

  • Amount: $100,000
  • Duration: 2 years

Scope

2020 Focus: Contributions to the development of breakthrough live cell analysis technologies for measuring cellular responses to chemical/pharmaceutical treatments and genetic manipulations, including those that could advance cell-based therapies.

The purpose of the Agilent Early Career Professor Award is to:

  • Promote and encourage excellent research enabling measurements of importance to Agilent Technologies and the world
  • Establish strong collaborative relationships between Agilent researchers and leading professors early in their career
  • Build the prominence of Agilent as a sponsor of university research

Award Information:

  • An unrestricted research award of $100,000 to be distributed in 2 years to university in the professor’s name
    • Option to use all or part of award to obtain Agilent products at 50% discount
    • Option to accelerate payments to facilitate procurement of equipment with list price over $100,000
  • Engraved plaque commemorating award
  • Recognition on Agilent’s website

Eligibility & Submission Requirements

Only one applicant from a university will be considered. Institutions are requested to have an internal screening and selection process. If you are interested in applying for this award, please contact Karen Drew (x4824) as soon as possible and submit a CV and 2-page pre-proposal following the NU Procedure for Programs with Limited Submissions.

Selection Criteria:

  • Professor completion of Ph.D. (or completion of residency for M.D. or M.D. – Ph.D.) no earlier than January 2010.
  • Significant original research contributions enabling measurements of importance to Agilent Technologies and the world
  • Outstanding potential for future research
  • Alignment with the 2020 Focus: Contributions to the development of breakthrough live cell analysis technologies for measuring cellular responses to chemical/pharmaceutical treatments and genetic manipulations, including those that could advance cell-based therapies.